{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:27:13Z","timestamp":1791354433896,"version":"4.3.1"},"reference-count":68,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Eighteen previously undescribed trimethoprim (TMP) analogs containing amide bonds (1\u201318) were synthesized and compared with TMP, methotrexate (MTX), and netropsin (NT). These compounds were designed as potential minor groove binding agents (MGBAs) and inhibitors of human dihydrofolate reductase (hDHFR). The all-new derivatives were obtained via solid phase synthesis using 4-nitrophenyl Wang resin. Data from the ethidium displacement test confirmed their DNA-binding capacity. Compounds 13\u201314 (49.89% and 43.85%) and 17\u201318 (41.68% and 42.99%) showed a higher binding affinity to pBR322 plasmid than NT. The possibility of binding in a minor groove as well as determination of association constants were performed using calf thymus DNA, T4 coliphage DNA, poly (dA-dT)2, and poly (dG-dC)2. With the exception of compounds 9 (IC50 = 56.05 \u00b5M) and 11 (IC50 = 55.32 \u00b5M), all of the compounds showed better inhibitory properties against hDHFR than standard, which confirms that the addition of the amide bond into the TMP structures increases affinity towards hDHFR. Derivatives 2, 6, 13, 14, and 16 were found to be the most potent hDHFR inhibitors. This molecular modelling study shows that they interact strongly with a catalytically important residue Glu-30.<\/jats:p>","DOI":"10.3390\/ijms22073685","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T10:44:01Z","timestamp":1617273841000},"page":"3685","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Synthesis, Biological Activity, and Molecular Dynamics Study of Novel Series of a Trimethoprim Analogs as Multi-Targeted Compounds: Dihydrofolate Reductase (DHFR) Inhibitors and DNA-Binding Agents"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4493-1547","authenticated-orcid":false,"given":"Agnieszka","family":"Wr\u00f3bel","sequence":"first","affiliation":[{"name":"Department of Organic Chemistry, Medical University of Bialystok, 15-222 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Baradyn","sequence":"additional","affiliation":[{"name":"Department of Physical Chemistry, Institute of Chemistry, University of Bialystok, 15-245 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1657-1871","authenticated-orcid":false,"given":"Artur","family":"Ratkiewicz","sequence":"additional","affiliation":[{"name":"Department of Physical Chemistry, Institute of Chemistry, University of Bialystok, 15-245 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3479-0480","authenticated-orcid":false,"given":"Danuta","family":"Drozdowska","sequence":"additional","affiliation":[{"name":"Department of Organic Chemistry, Medical University of Bialystok, 15-222 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2174\/092986706775527938","article-title":"Towards species-specific antifolates","volume":"13","author":"Chan","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"ref_2","unstructured":"Champe, P.C., and Harvey, R.A. (1994). Lippincott\u2019s Illustrated Reviews, Lippincott Williams and Wilkins. [2nd ed.]."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.bcp.2005.10.052","article-title":"Dihydrofolate reductase inhibitors as antibacterial agents","volume":"71","author":"Hawser","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13065-019-0603-x","article-title":"Design, synthesis, and biological evaluation of novel N4-substituted sulfonamides: Acetamides derivatives as dihydrofolate reductase (DHFR) inhibitors","volume":"13","author":"Hussein","year":"2019","journal-title":"BMC Chem."},{"key":"ref_5","first-page":"23","article-title":"Eukaryotic dihydrofolate reductase","volume":"70","author":"Blakley","year":"1995","journal-title":"Adv. Enzymol. Relat. Areas Mol. Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/prot.22383","article-title":"Structural comparison of chromosomal and exogenous dihydrofolate reductase from Staphylococcus aureus in complex with the potent inhibitor trimethoprim","volume":"76","author":"Heaslet","year":"2009","journal-title":"Proteins"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"15328","DOI":"10.1038\/srep15328","article-title":"The identification of novel Mycobacterium tuberculosis DHFR inhibitors and the investigation of their binding preferences by using molecular modelling","volume":"5","author":"Hong","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Raimondi, M.V., Randazzo, O., La Franca, M., Barone, G., Vignoni, E., Rossi, D., and Collina, S. (2019). DHFR inhibitors: Reading the past for discovering novel anticancer agents. Molecules, 24.","DOI":"10.3390\/molecules24061140"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1021\/acs.biochem.5b01364","article-title":"Ligand-dependent conformational dynamics of dihydrofolate reductase","volume":"55","author":"Reddish","year":"2016","journal-title":"Biochemistry"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0014-2964(77)90118-9","article-title":"Acquired methotrexate resistance in lymphoblasts resulting from altered kinetic properties of dihydrofolate reductase","volume":"13","author":"Jackson","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Singh, A., Deshpande, N., Pramanik, N., Jhunjhunwala, S., Rangarajan, A., and Atreya, H.S. (2018). Optimized peptide based inhibitors targeting the dihydrofolate reductase pathway in cancer. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-21435-5"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1021\/jm991119p","article-title":"Design and synthesis of cyclopenta[g]quinazoline-based antifolates as inhibitors of thymidylate synthase and potential antitumor agents","volume":"43","author":"Bavetsias","year":"2000","journal-title":"J. Med. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1021\/jm00394a038","article-title":"Antimalarial drugs. 63. Synthesis and antimalarial and antitumor effects of 2-amino-4-(hydrazino and hydroxyamino)-6-[(aryl)thio]quinazolines","volume":"30","author":"Werbel","year":"1987","journal-title":"J. Med. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.bmcl.2005.01.083","article-title":"Synthesis and in vitro antitumor activity of 4(3H)-quinazolione derivatives with dithiocarbamate side chains","volume":"15","author":"Cao","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1021\/jm020495y","article-title":"Novel dihydrofolate reductase inhibitors. Structure-based versus diversity-based library design and high-throughput synthesis and screening","volume":"46","author":"Wyss","year":"2003","journal-title":"J. Med. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1021\/jm00106a001","article-title":"The renewed potential for folate antagonists in contemporary cancer chemotherapy","volume":"34","author":"Berman","year":"1991","journal-title":"J. Med. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41584-020-0373-9","article-title":"Methotrexate and its mechanisms of action in inflammatory arthritis","volume":"16","author":"Cronstein","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1021\/jm00177a025","article-title":"Synthesis and antitumor activity of 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methylpyrido 2,3-d]pyrimidine","volume":"23","author":"Grivsky","year":"1980","journal-title":"J. Med. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0921-4410(03)21001-2","article-title":"Thymidylate synthase inhibitors","volume":"21","author":"Ackland","year":"2003","journal-title":"Cancer Chemother. Biol. Response Modif."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.drup.2014.10.002","article-title":"The folate receptor as a rational therapeutic target for personalized cancer treatment","volume":"17","author":"Assaraf","year":"2014","journal-title":"Drug Resist. Updat."},{"key":"ref_21","first-page":"1","article-title":"Recent design and structure-activity relationship studies on modifications of DHFR inhibitors as anticancer agents","volume":"26","author":"Drozdowska","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"ref_22","unstructured":"(2020, March 20). Drugs.com Trimethoprim. Available online: https:\/\/www.drugs.com\/pro\/trimethoprim.html."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2165\/00003495-198223060-00001","article-title":"Trimethoprim: A Review of its antibacterial activity, pharmacokinetics and therapeutic use in urinary tract infections","volume":"23","author":"Brogden","year":"1982","journal-title":"Drugs"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Villa, D., Aguilar, M.R., Rojo, L., and Villa, F. (2019). Rojo Folic Acid Antagonists: Antimicrobial and Immunomodulating Mechanisms and Applications. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20204996"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/j.1875-9114.1981.tb03548.x","article-title":"Trimethoprim: Mechanisms of action, antimicrobial activity, bacterial resistance, pharmacokinetics, adverse reactions, and therapeutic indications","volume":"1","author":"Gleckman","year":"1981","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"key":"ref_26","first-page":"5","article-title":"Trimethoprim and other non-classical antifolates an excellent template for searching modifications of dihydrofolate reductase enzyme inhibitors","volume":"73","author":"Arciszewska","year":"2019","journal-title":"J. Antibiot."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.1021\/jm300644g","article-title":"Mechanism Inspired Development of Rationally Designed Dihydrofolate Reductase Inhibitors as Anticancer Agents","volume":"55","author":"Singh","year":"2012","journal-title":"J. Med. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jmgm.2010.11.004","article-title":"2,4-Diamino-5-(2\u2032-aryl-propargyl) pyrimidine derivatives as new nonclassical antifolates for human dihydrofolate reductase inhibition","volume":"9","author":"Algul","year":"2011","journal-title":"J. Mol. Graph. Model"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.bmc.2005.09.011","article-title":"The benefits of the multi-target approach in drug design and discovery","volume":"14","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.2174\/092986711797535344","article-title":"Designed multiple ligands for cancer therapy","volume":"18","author":"Meegan","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2174\/1389557518666181009143203","article-title":"Carbocyclic analogues of distamycin and netropsin","volume":"19","author":"Arciszewska","year":"2018","journal-title":"Mini-Reviews Med. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Jeon, H., Nam, H., and Lee, J.B. (2019). Sustained release of minor-groove-binding antibiotic netropsin from calcium-coated groove-rich DNA particles. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11080387"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1016\/S0021-9258(19)39400-1","article-title":"Kinetics of the formation and isomerization of methotrexate complexes of recombinant human dihydrofolate reductase","volume":"265","author":"Appleman","year":"1990","journal-title":"J. Biol. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"11475","DOI":"10.1016\/S0021-9258(19)86510-9","article-title":"Porcine liver dihydrofolate reductase. Purification, properties, and amino acid sequence","volume":"254","author":"Smith","year":"1979","journal-title":"J. Biol. Chem."},{"key":"ref_35","first-page":"377","article-title":"Crystal structure of human dihydrofolate reductase complexed with folate","volume":"174","author":"Oefner","year":"1988","journal-title":"JBIC J. Biol. Inorg. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1021\/bi00339a008","article-title":"Theoretical studies on the activation of the pterin cofactor in the catalytic mechanism of dihydrofolate reductase","volume":"24","author":"Gready","year":"1985","journal-title":"Biochemistry"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"18225","DOI":"10.1073\/pnas.1415856111","article-title":"Toward resolving the catalytic mechanism of dihydrofolate reductase using neutron and ultrahigh-resolution X-ray crystallography","volume":"111","author":"Wan","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1021\/ci400178h","article-title":"Molecular modeling study of dihydrofolate reductase inhibitors. Molecular dynamics simulations, quantum mechanical calculations, and experimental corroboration","volume":"53","author":"Tosso","year":"2013","journal-title":"J. Chem. Inf. Model."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"22721","DOI":"10.1074\/jbc.M500277200","article-title":"Identification of amino acids required for the functional up-regulation of human dihydrofolate reductase protein in response to antifolate treatment","volume":"280","author":"Skacel","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ejmech.2018.05.059","article-title":"Synthesis, biological evaluation and molecular modeling of novel azaspiro dihydrotriazines as influenza virus inhibitors targeting the host factor dihydrofolate reductase (DHFR)","volume":"155","author":"Francesconi","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Rana, R.M., Rampogu, S., Zeb, A., Son, M., Park, C., Lee, G., Yoon, S., Baek, A., Parameswaran, S., and Park, S.J. (2019). In silico study probes potential inhibitors of human dihydrofolate reductase for cancer therapeutics. J. Clin. Med., 8.","DOI":"10.3390\/jcm8020233"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Wr\u00f3bel, A., Maliszewski, D., Baradyn, M., and Drozdowska, D. (2019). Trimethoprim: An old antibacterial drug as a template to search for new targets. Synthesis, biological activity and molecular modeling study of novel trimethoprim analogs. Molecules, 25.","DOI":"10.3390\/molecules25010116"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2174\/157340812800793264","article-title":"Recent progress in molecular dynamics simulations of dihydrofolate reductase","volume":"8","author":"Kerrigan","year":"2012","journal-title":"Curr. Enzym. Inhib."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Drozdowska, D., and Drozdowska, D. (2011). New solid phase synthesis of distamycin analogues. Molecules, 16.","DOI":"10.3390\/molecules16043066"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"11300","DOI":"10.3390\/molecules190811300","article-title":"Semi-automatic synthesis, antiproliferative activity and dna-binding properties of new netropsin and bis-netropsin analogues","volume":"19","author":"Szerszenowicz","year":"2014","journal-title":"Molecules"},{"key":"ref_47","first-page":"47","article-title":"Antiproliferative effects on breast cancer cells and some interactions of new distamycin analogues with dna, endonucleases and dna topoisomerases","volume":"73","author":"Drozdowska","year":"2016","journal-title":"Acta Pol. Pharm. Drug Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1021\/jm00125a024","article-title":"Synthesis, DNA binding and biological evaluation of synthetic precursors and novel analogs of netropsin","volume":"32","author":"Debart","year":"1989","journal-title":"J. Med. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Dong, Z., Abbas, M.N., Kausar, S., Yang, J., Li, L., Tan, L., and Cui, H. (2019). Biological functions and molecular mechanisms of antibiotic tigecycline in the treatment of cancers. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20143577"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Pinzi, L., and Rastelli, G. (2019). Molecular docking: Shifting paradigms in drug discovery. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20184331"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3389\/fphar.2018.01089","article-title":"Empirical scoring functions for structure-based virtual screening: Applications, critical aspects, and challenges","volume":"9","author":"Guedes","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_52","unstructured":"BIOVIA (2021). Dassault Syst\u00e8mes. Discovery Studio Visualizer. v21.1.0.20298, Dassault Syst\u00e8mes."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1107\/S0907444904030422","article-title":"Understanding the role of Leu22 variants in methotrexate resistance: Comparison of wild-type and Leu22Arg variant mouse and human dihydrofolate reductase ternary crystal complexes with methotrexate and NADPH","volume":"61","author":"Cody","year":"2005","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"ref_54","unstructured":"Leung, A., Reynolds, R., and Borhani, D. (2021, March 01). Human dihydrofolate reductase complexed with nadph and trimethoprim. Available online: https:\/\/www.rcsb.org\/structure\/2W3A."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"7318","DOI":"10.1021\/bi400852h","article-title":"Elucidating features that drive the design of selective antifolates using crystal structures of human dihydrofolate reductase","volume":"52","author":"Lamb","year":"2013","journal-title":"Biochemistry"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Pedrola, M., Jorba, M., Jardas, E., Jardi, F., Ghashghaei, O., Vi\u00f1as, M., and Lavilla, R. (2019). Multicomponent reactions upon the known drug trimethoprim as a source of novel antimicrobial agents. Front. Chem., 7.","DOI":"10.3389\/fchem.2019.00475"},{"key":"ref_57","first-page":"115","article-title":"Carbocyclic analogues of lexitropsin--DNA affinity and endonuclease inhibition","volume":"64","author":"Drozdowska","year":"2007","journal-title":"Acta Pol. Pharm. Drug Res."},{"key":"ref_58","unstructured":"Sigma Aldrich (2021, March 01). Technical Bulletin. Available online: https:\/\/www.sigmaaldrich.com\/content\/dam\/sigmaaldrich\/docs\/Sigma\/Bulletin\/cs0340bul.pdf."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"044130","DOI":"10.1063\/5.0014475","article-title":"Scalable molecular dynamics on CPU and GPU architectures with NAMD","volume":"153","author":"Phillips","year":"2020","journal-title":"J. Chem. Phys."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1021\/ct300400x","article-title":"Optimization of the additive charmm all-atom protein force field targeting improved sampling of the backbone \u03d5, \u03c8 and side-chain \u03c71 and \u03c72 dihedral angles","volume":"8","author":"Best","year":"2012","journal-title":"J. Chem. Theory Comput."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","article-title":"CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields","volume":"31","author":"Vanommeslaeghe","year":"2009","journal-title":"J. Comput. Chem."},{"key":"ref_62","unstructured":"(2021, March 01). The CHARMM General Force Field (CGenFF) Program. Available online: https:\/\/cgenff.umaryland.edu."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/jcc.23422","article-title":"Rapid parameterization of small molecules using the force field toolkit","volume":"34","author":"Mayne","year":"2013","journal-title":"J. Comput. Chem."},{"key":"ref_64","unstructured":"Frisch, M.J., Trucks, G.W., Schlegel, H.B., Scuseria, G.E., Robb, M.A., Cheeseman, J.R., Scalmani, G., Barone, V., Petersson, G.A., and Nakatsuji, H. (2016). Gaussian 16, Revision C.01, Gaussian. Inc."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: Visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1515\/pac-2013-0201","article-title":"Definition of terms relating to individual macromolecules, macromolecular assemblies, polymer solutions, and amorphous bulk poliymers (IUPAC Recommendations 2014)","volume":"87","author":"Stepto","year":"2015","journal-title":"Pure Appl. Chem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1134\/S0026893308040195","article-title":"Radius of gyration as an indicator of protein structure compactness","volume":"42","author":"Lobanov","year":"2008","journal-title":"Mol. Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"456","DOI":"10.2174\/1389203715666140327114232","article-title":"A review of methods available to estimate solvent-accessible surface areas of soluble proteins in the folded and unfolded states","volume":"15","author":"Ali","year":"2014","journal-title":"Curr. Protein Pept. Sci."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/7\/3685\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:10:56Z","timestamp":1760364656000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/7\/3685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":68,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,4]]}},"alternative-id":["ijms22073685"],"URL":"https:\/\/doi.org\/10.3390\/ijms22073685","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]}}}